DrugJan 24, 2018
Shiseido Future Solution LX Discovery Set contains SPF 50+ recall — FDA D-0216-2018
GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.
Class IIFDA: TerminatedSHISEIDO AMERICA Inc.
10,690drug recall records
953FDA Class I records
8firms with 5+ records
Aidapak Services, LLC537 records
Database records
Records — page 227
10,690 detailed records are currently available in this category.
DrugJan 24, 2018
Pharmedium Services ePHEDrine Sulfate In 0.9% Sodium Chloride, 5 mg per mL recall — FDA D-0220-2018
Subpotent Drug
Class IIFDA: TerminatedPharmedium Services, LLC
DrugJan 24, 2018
Divalproex Sodium Delayed Release Tablets USP, 500 mg, 100-count bottle recall — FDA D-0228-2018
Cross Contamination With Other Products: metronidazole powder was found in one bottle of Divalproex Sodium.
Class IIFDA: TerminatedUnichem Pharmaceuticals Usa Inc.
DrugJan 24, 2018
SHISEIDO bareMinerals Broad Spectrum SPF 50 Daily Prep Lotion recall — FDA D-0214-2018
GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.
Class IIFDA: TerminatedSHISEIDO AMERICA Inc.
DrugJan 24, 2018
Pharmatech Rugby Diocto Liquid, Docusate Sodium 50 mg/ 5 mL, Stool Softener Laxative, One recall — FDA D-0224-2018
Microbial Contamination of Non Sterile Product; presence of yeast and potential B. cepacia contamination
Class IIFDA: TerminatedPharmatech LLC
DrugJan 24, 2018
Shiseido Future Solution LX Luxurious Eye & Lip Collection contains SPF 50+ recall — FDA D-0217-2018
GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.
Class IIFDA: TerminatedSHISEIDO AMERICA Inc.
DrugJan 24, 2018
Simvastatin Tablets, USP, 40 mg, 1000-count bottle recall — FDA D-0223-2018
Presence of foreign substance: metallic razor blade was found in one bottle.
Class IIIFDA: TerminatedHetero Labs, Ltd. - Unit III
DrugJan 24, 2018
Shiseido Future Solutions LX Triple Points Bonus contains SPF 50+ recall — FDA D-0218-2018
GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.
Class IIFDA: TerminatedSHISEIDO AMERICA Inc.
DrugJan 24, 2018
Pharmatech Rugby Senexon Liquid Natural Vegetable Stimulant,(Sennosides) 8.8 mg, 8 fl oz recall — FDA D-0226-2018
Microbial Contamination of Non Sterile Product; presence of yeast and potential B. cepacia contamination
Class IIFDA: TerminatedPharmatech LLC
DrugJan 17, 2018
KRS Global Biotechnology Human Chorionic Gonadotropin 6,000 iu/Vial, For SC Use -Lyophilized recall — FDA D-0176-2018
Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
Class IIFDA: TerminatedKRS Global Biotechnology, Inc.
DrugJan 17, 2018
KRS Global Biotechnology Benzocaine 20%, Lidocaine 6%, Tetracaine 4% Cream recall — FDA D-0165-2018
Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
Class IIFDA: TerminatedKRS Global Biotechnology, Inc.
DrugJan 17, 2018
KRS Global Biotechnology Savinase 100 mcg/mL Topical Solution, 1 mL in a 3 mL Droptainer recall — FDA D-0192-2018
Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
Class IIFDA: TerminatedKRS Global Biotechnology, Inc.
DrugJan 17, 2018
KRS Global Biotechnology Chloramphenicol 50 mg/ Sulfamethoxazole 50 mg/ Amphotericin-B 5 mg recall — FDA D-0169-2018
Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
Class IIFDA: TerminatedKRS Global Biotechnology, Inc.
DrugJan 17, 2018
KRS Global Biotechnology Progesterone 3% Topical Cream recall — FDA D-0188-2018
Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
Class IIFDA: TerminatedKRS Global Biotechnology, Inc.
DrugJan 17, 2018
KRS Global Biotechnology QUADMIX #18, 5 mL Vial recall — FDA D-0191-2018
Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
Class IIFDA: TerminatedKRS Global Biotechnology, Inc.
DrugJan 17, 2018
KRS Global Biotechnology Human Chorionic Gonadotropin 2,500 Units, Vial-Lyophilized, For SC recall — FDA D-0174-2018
Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
Class IIFDA: TerminatedKRS Global Biotechnology, Inc.
DrugJan 17, 2018
KRS Global Biotechnology Hydroquinone 8%/ Tretinoin 0.1% Topical Ointment recall — FDA D-0179-2018
Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
Class IIFDA: TerminatedKRS Global Biotechnology, Inc.
DrugJan 17, 2018
KRS Global Biotechnology Bi-Est (Estriol/Estradiol) (80/20) + Progesterone 7.5 mg/200 mg recall — FDA D-0168-2018
Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
Class IIFDA: TerminatedKRS Global Biotechnology, Inc.
DrugJan 17, 2018
KRS Global Biotechnology Benzo/Lido/Tetracaine 20%-8%-8% Topical Cream recall — FDA D-0167-2018
Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
Class IIFDA: TerminatedKRS Global Biotechnology, Inc.
DrugJan 17, 2018
KRS Global Biotechnology Methylene Blue (PF) 10 mg/mL (1%) Injectable Vial recall — FDA D-0184-2018
Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
Class IIFDA: TerminatedKRS Global Biotechnology, Inc.
DrugJan 17, 2018
KRS Global Biotechnology Vitamin 9 A/B Lyophilized Vial, For IM Use recall — FDA D-0204-2018
Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
Class IIFDA: TerminatedKRS Global Biotechnology, Inc.
DrugJan 17, 2018
Valsartan Tablets, USP, 160 mg, 90-count bottles recall — FDA D-0209-2018
Failed Tablet/Capsule Specifications: confirmed customer complaint of thicker and heavier tablets in bottle.
Class IIFDA: TerminatedPrinston Pharmaceutical Inc.
DrugJan 17, 2018
KRS Global Biotechnology Anastrozole 0.5 mg Capsules recall — FDA D-0161-2018
Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
Class IIFDA: TerminatedKRS Global Biotechnology, Inc.
DrugJan 17, 2018
KRS Global Biotechnology Liothyronine SR (T3) 20 mcg Capsule recall — FDA D-0183-2018
Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
Class IIFDA: TerminatedKRS Global Biotechnology, Inc.
How to use this drug recall index
A drug recall record can include the reason for recall, firm, status, distribution pattern, quantity and FDA classification. This site does not provide medical advice; it organizes public recall information and links users back to official sources.
Recall Lookup USA keeps the last complete source record available when an official data service is temporarily unavailable. When a source provides only a few fields, we show only those known facts rather than padding the page with generic text.
What the database can and cannot tell you
This database is designed for discovery and reference. It can help you locate a relevant recall record, identify the recalling firm or NHTSA campaign, compare dates and classifications, and follow the official source. It is not a substitute for a VIN-specific NHTSA check, a manufacturer notice, medical advice or instructions issued by the recalling company.